1. Home
  2. CLBK vs ANIP Comparison

CLBK vs ANIP Comparison

Compare CLBK & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbia Financial Inc.

CLBK

Columbia Financial Inc.

HOLD

Current Price

$10.81

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$79.45

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLBK
ANIP
Founded
1927
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
2026
1999

Fundamental Metrics

Financial Performance
Metric
CLBK
ANIP
Price
$10.81
$79.45
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$17.00
$110.00
AVG Volume (30 Days)
6.7M
238.1K
Earning Date
04-20-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
419.23
EPS
N/A
1.28
Revenue
N/A
$206,547,000.00
Revenue This Year
$3.97
$21.01
Revenue Next Year
$11.43
$17.59
P/E Ratio
$83.69
$62.88
Revenue Growth
N/A
2.47
52 Week Low
$10.70
$63.67
52 Week High
$25.83
$99.50

Technical Indicators

Market Signals
Indicator
CLBK
ANIP
Relative Strength Index (RSI) 21.97 44.35
Support Level $10.70 $76.87
Resistance Level $16.27 $83.66
Average True Range (ATR) 0.56 2.22
MACD -0.81 -0.04
Stochastic Oscillator 0.83 34.61

Price Performance

Historical Comparison
CLBK
ANIP

About CLBK Columbia Financial Inc.

Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a customer service-focused institution. The company offers traditional financial services to businesses and consumers in its market areas. It attracts deposits from the general public and uses those funds to originate various loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans. The company also offers title insurance through its wholly owned subsidiary and provides a broad range of insurance products, including personal and business lines of insurance, mainly to customers and New Jersey residents.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: